Folyóiratcikkek tallózása szerző szerint "Koletzko S"

1-4 / 4

Comparison of Outcomes Parameters for Induction of Remission in New Onset Pediatric Crohn's Disease: Evaluation of the Porto IBD Group "Growth Relapse and Outcomes with Therapy" (GROWTH CD) Study.

Levine A; Turner D; Pfeffer Gik T; Amil Dias J; Veres, Gábor; Shaoul R; Staiano A; Escher J; Kolho KL; Paerregaard A; Martin de Carpi J; Veereman Wauters G; Koletzko S; Shevah O; Finnby L; Sladek M (2014)

BACKGROUND: Robust evaluation of induction therapies using both clinical and inflammatory outcomes in pediatric Crohn's disease (CD) are sparse. We attempted to evaluate clinical, inflammatory, and composite outcomes of ...
Diagnostic approach and management of cow's milk protein allergy in infants and children

Koletzko S; Niggemann B; Arató, András; Dias JA; Heuschkel R; Husby S; Mearin ML; Papadopoulou A; Ruemmele FM; Staiano A; Schappi MG; Vandenplas Y (2012)

OBJECTIVES:: This position paper provides recommendations for the diagnosis and management of suspected cow's milk protein allergy (CMPA) in Europe. It presents a practical approach with a diagnostic algorithm and is based ...
Malignancy and Mortality in Pediatric Patients with Inflammatory Bowel Disease: A Multinational Study from the Porto Pediatric IBD Group.

de Ridder L; Turner D; Wilson DC; Koletzko S; Martin-de-Carpi J; Fagerberg UL; Spray C; Sladek M; Shaoul R; Roma-Giannikou E; Bronsky J; Serban DE; Cucchiara S; Veres, Gábor; Ruemmele FM; Hojsak I; Kolho KL; Davies IH; Aloi M; Lionetti P; Veereman-Wauters G; Braegger CP; Trindade E; Wewer AV; Hauer A; Levine A (2014)

BACKGROUND: The combination of the severity of pediatric-onset inflammatory bowel disease (IBD) phenotypes and the need for intense medical treatment may increase the risk of malignancy and mortality, but evidence regarding ...
Risk of infection and prevention in pediatric patients with IBD: ESPGHAN IBD Porto group commentary

Veereman-Wauters G; De Ridder L; Veres, Gábor; Kolacek S; Fell J; Malmborg P; Koletzko S; Dias JA; Misak Z; Rahier J-F; Escher JC; ESPGHAN IBD Porto Group (2012)

Combined immunosuppression by immunomodulators and biological therapy has become standard in the medical management of moderate-tosevere inflammatory bowel disease (IBD) because of clearly demonstrated efficacy. Clinical ...

1-4 / 4

Keresés

Összetett keresés

Tallózás

Teljes repozitórumban
Ebben a gyűjteményben

Hozzáférésem

Bejelentkezés

Folyóiratcikkek tallózása szerző szerint "Koletzko S"

DSpace/Manakin Repository

Folyóiratcikkek tallózása szerző szerint "Koletzko S"

Keresés

Tallózás

Teljes repozitórumban

Ebben a gyűjteményben

Hozzáférésem